Binding of the hemopressin peptide to the cannabinoid CB1 receptor: Structural insights

Biochemistry

Volumn 49, Issue 49, 2010, Pages 10449-10457

  Scrima, Mario ^a   Di Marino, Sara ^a   Grimaldi, Manuela ^a   Mastrogiacomo, Antonia ^a   Novellino, Ettore ^b   Bifulco, Maurizio ^a   D'Ursi, Anna Maria ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING MODES; CIRCULAR DICHROISM; CONFORMATIONAL ANALYSIS; DRUG ABUSE; EFFECTIVE INTERACTIONS; MOLECULAR DOCKING; OBESITY DRUGS; PHARMACOPHORE MODELS; RECEPTOR ANTAGONISTS; SIDE EFFECT; STRUCTURAL INSIGHTS; THERAPEUTIC APPLICATION; THERAPEUTIC USE; TURN STRUCTURE;

BINDING ENERGY; CONFORMATIONS; DICHROISM; DOCKING; DRUG INTERACTIONS; LEAD COMPOUNDS; MAGNETIC RESONANCE; MOLECULAR MODELING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUTRITION;

CIRCULAR DICHROISM SPECTROSCOPY;

CANNABINOID 1 RECEPTOR; HEMOPRESSIN; NONAPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CIRCULAR DICHROISM; CONFORMATION; MOLECULAR DOCKING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; BINDING SITES; CIRCULAR DICHROISM; HEMOGLOBINS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTOR, CANNABINOID, CB1;

EID: 78650148680     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi1011833     Document Type: Article

References (72)

1. Heimann, A. S., Gomes, I., Dale, C. S., Pagano, R. L., Gupta, A., de Souza, L. L., Luchessi, A. D., Castro, L. M., Giorgi, R., Rioli, V., Ferro, E. S., and Devi, L. A. (2007) Hemopressin is an inverse agonist of CB1 cannabinoid receptors Proc. Natl. Acad. Sci. U.S.A. 104, 20588-20593
2. De Petrocellis, L., Cascio, M. G., and Di Marzo, V. (2004) The endocannabinoid system: A general view and latest additions Br. J. Pharmacol. 141, 765-774
3. Cota, D. and Woods, S. C. (2005) The role of the endocannabinoid system in the regulation of energy homeostasis Curr. Opin. Endocrinol. Diabetes 12, 338-351
4. Pagotto, U., Marsicano, G., Cota, D., Lutz, B., and Pasquali, R. (2006) The emerging role of the endocannabinoid system in endocrine regulation and energy balance Endocr. Rev. 27, 73-100
5. Panikashvili, D., Simeonidou, C., Ben-Shabat, S., Hanus, L., Breuer, A., Mechoulam, R., and Shohami, E. (2001) An endogenous cannabinoid (2-AG) is neuroprotective after brain injury Nature 413, 527-531
6. Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutierrez, S. O., van der Stelt, M., Lopez-Rodriguez, M. L., Casanova, E., Schutz, G., Zieglgansberger, W., Di Marzo, V., Behl, C., and Lutz, B. (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity Science 302, 84-88
7. Panikashvili, D., Mechoulam, R., Beni, S. M., Alexandrovich, A., and Shohami, E. (2005) CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition J. Cereb. Blood Flow Metab. 25, 477-484
8. Cravatt, B. F. and Lichtman, A. H. (2004) The endogenous cannabinoid system and its role in nociceptive behavior J. Neurobiol. 61, 149-160
9. Walter, L., Franklin, A., Witting, A., Wade, C., Xie, Y., Kunos, G., Mackie, K., and Stella, N. (2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration J. Neurosci. 23, 1398-1405
10. Klein, T. W., Newton, C., Larsen, K., Lu, L., Perkins, I., Nong, L., and Friedman, H. (2003) The cannabinoid system and immune modulation J. Leukocyte Biol. 74, 486-496
11. Massa, F., Marsicano, G., Hermann, H., Cannich, A., Monory, K., Cravatt, B. F., Ferri, G. L., Sibaev, A., Storr, M., and Lutz, B. (2004) The endogenous cannabinoid system protects against colonic inflammation J. Clin. Invest. 113, 1202-1209
12. Bifulco, M., Malfitano, A. M., Pisanti, S., and Laezza, C. (2008) Endocannabinoids in endocrine and related tumours Endocr.-Relat. Cancer 15, 391-408
13. Croxford, J. (2003) Therapeutic potential of cannabinoids in CNS disease CNS Drugs 17, 179-202
14. Drysdale, A. and Platt, B. (2003) Cannabinoids: Mechanisms and therapeutic applications in the CNS Curr. Med. Chem. 10, 2719-2732
15. Ligresti, A., Bisogno, T., Matias, I., De Petrocellis, L., Cascio, M., Cosenza, V., D'argenio, G., Scaglione, G., Bifulco, M., and Sorrentini, I. (2003) Possible endocannabinoid control of colorectal cancer growth Gastroenterology 125, 677-687
16. Croxford, J. and Miller, S. (2004) Towards cannabis and cannabinoid treatment of multiple sclerosis Drugs Today 40, 663-676
17. Smith, P. (2004) Medicinal cannabis extracts for the treatment of multiple sclerosis Curr. Opin. Invest. Drugs (Thomson Sci.) 5, 727-730
18. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., and Bonner, T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346, 561-564
19. Munro, S., Thomas, K. L., and Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids Nature 365, 61-65
20. Galiegue, S., Mary, S., Marchand, J., Dussossoy, D., Carriere, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G., and Casellas, P. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations Eur. J. Biochem. 232, 54-61
21. 1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo Biochem. J. 351 (Part 3) 817-824
22. Huang, S. M., Bisogno, T., Trevisani, M., Al-Hayani, A., De Petrocellis, L., Fezza, F., Tognetto, M., Petros, T. J., Krey, J. F., Chu, C. J., Miller, J. D., Davies, S. N., Geppetti, P., Walker, J. M., and Di Marzo, V. (2002) An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors Proc. Natl. Acad. Sci. U.S.A. 99, 8400-8405
23. Porter, A. C., Sauer, J. M., Knierman, M. D., Becker, G. W., Berna, M. J., Bao, J., Nomikos, G. G., Carter, P., Bymaster, F. P., Leese, A. B., and Felder, C. C. (2002) Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor J. Pharmacol. Exp. Ther. 301, 1020-1024
24. 2 receptor-mediated signalling: A focus on endocannabinoids Prostaglandins, Leukotrienes Essent. Fatty Acids 66, 161-171
25. Mechoulam, R., Panikashvili, D., and Shohami, E. (2002) Cannabinoids and brain injury: Therapeutic implications Trends Mol. Med. 8, 58-61
26. Fernandez, J. and Allison, D. (2004) Rimonabant Sanofi-Synthélabo Curr. Opin. Invest. Drugs (Thomson Sci.) 5, 430-435
27. Black, S. (2004) Cannabinoid receptor antagonists and obesity Curr. Opin. Invest. Drugs (Thomson Sci.) 5, 389-394
28. Hungund, B., Basavarajappa, B., Vadasz, C., Kunos, G., de Fonseca, F., Colombo, G., Serra, S., Parsons, L., and Koob, G. (2006) Ethanol, endocannabinoids, and the cannabinoidergic signaling system Alcohol.: Clin. Exp. Res. 26, 565-574
29. Solinas, M., Panlilio, L., Antoniou, K., Pappas, L., and Goldberg, S. (2003) The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats J. Pharmacol. Exp. Ther. 306, 93
30. Dale, C. S., Pagano Rde, L., and Rioli, V. (2005) Hemopressin: A novel bioactive peptide derived from the α1-chain of hemoglobin Mem. Inst. Oswaldo Cruz 100 (Suppl. 1) 105-106
31. Dale, C. S., Pagano Rde, L., Rioli, V., Hyslop, S., Giorgi, R., and Ferro, E. S. (2005) Antinociceptive action of hemopressin in experimental hyperalgesia Peptides 26, 431-436
32. Pellegrini, M. and Mierke, D. F. (1999) Structural characterization of peptide hormone/receptor interactions by NMR spectroscopy Biopolymers 51, 208-220
33. Weller, K., Lauber, S., Lerch, M., Renaud, A., Merkle, H. P., and Zerbe, O. (2005) Biophysical and biological studies of end-group-modified derivatives of Pep-1 Biochemistry 44, 15799-15811
34. Whitmore, L. and Wallace, B. (2004) DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data Nucleic Acids Res. 32, W668
35. Wesson, L. and Eisenberg, D. (1992) Atomic solvation parameters applied to molecular dynamics of proteins in solution Protein Sci. 1, 227-235
36. Piantini, U., Sorensen, O., and Ernst, R. (1982) Multiple quantum filters for elucidating NMR coupling networks J. Am. Chem. Soc. 104, 6800-6801
37. Bax, A. and Davis, D. (1985) MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy J. Magn. Reson. 65, 355-360
38. Jeener, J., Meier, B., Bachmann, P., and Ernst, R. (1979) Investigation of exchange processes by two-dimensional NMR spectroscopy J. Chem. Phys. 71, 4546-4553
39. Goddard, T. and Kneller, D. (2004) SPARKY 3, University of California, San Francisco.
40. Guntert, P., Mumenthaler, C., and Wuthrich, K. (1997) Torsion angle dynamics for NMR structure calculation with the new program DYANA J. Mol. Biol. 273, 283-298
41. Pearlman, D., Case, D., Caldwell, J., Ross, W., and Cheatham, T. (1995) AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules Comput. Phys. Commun. 91, 1-41
42. Case, D., Pearlman, D., Caldwell, J., Cheatham, T., III, Ross, W., Simmerling, C., Darden, T., Merz, K., Stanton, R., and Cheng, A. (1997) AMBER 5, University of California, San Francisco.
43. Thompson, J. D., Gibson, T. J., Plewniak, F., Jeanmougin, F., and Higgins, D. G. (1997) The CLUSTAL-X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools Nucleic Acids Res. 25, 4876-4882
44. Salo, O. M., Lahtela-Kakkonen, M., Gynther, J., Jarvinen, T., and Poso, A. (2004) Development of a 3D model for the human cannabinoid CB1 receptor J. Med. Chem. 47, 3048-3057
45. Sali, A. and Blundell, T. L. (1993) Comparative protein modelling by satisfaction of spatial restraints J. Mol. Biol. 234, 779-815
46. Fiser, A., Do, R. K., and Sali, A. (2000) Modeling of loops in protein structures Protein Sci. 9, 1753-1773
47. Eswar, N., Webb, B., Marti-Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M. Y., Pieper, U., and Sali, A. (2007) Comparative protein structure modeling using Modeller Curr. Protoc. Protein Sci., Chapter 2, Unit 2.9
48. Hurst, D. P., Lynch, D. L., Barnett-Norris, J., Hyatt, S. M., Seltzman, H. H., Zhong, M., Song, Z. H., Nie, J., Lewis, D., and Reggio, P. H. (2002) N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H- pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor Mol. Pharmacol. 62, 1274-1287
49. McAllister, S. D., Hurst, D. P., Barnett-Norris, J., Lynch, D., Reggio, P. H., and Abood, M. E. (2004) Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: The importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation J. Biol. Chem. 279, 48024-48037
50. Polak, E. and Ribiere, G. (1969) Note sur la convergence de directions conjugees Revue Francaise Informant Recherch Operationelle, Annee 16, 35-43
51. Laskowski, R., MacArthur, M., Moss, D., and Thornton, J. (1993) PROCHECK: A program to check the stereochemical quality of protein structures J. Appl. Crystallogr. 26, 283-291
52. Trott, O. and Olson, A. (2009) AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading J. Comput. Chem. 31, 455-461
53. Morris, G., Huey, R., Lindstrom, W., Sanner, M., Belew, R., Goodsell, D., and Olson, A. (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility J. Comput. Chem. 30, 2785-2791
54. Humphrey, W., Dalke, A., and Schulten, K. (1996) VMD: Visual molecular dynamics J. Mol. Graphics 14, 33-38
55. Sanner, M. F. (1999) Python: A programming language for software integration and development J. Mol. Graphics Modell. 17, 57-61
56. Sanner, M. F., Olson, A. J., and Spehner, J. C. (1996) Reduced surface: An efficient way to compute molecular surfaces Biopolymers 38, 305-320
57. 1H spin-spin coupling constants in proteins Biochem. Biophys. Res. Commun. 113, 967-974
58. Wüthrich, K. (1986) NMR of Proteins and Nucleic Acids, Wiley-Interscience, New York.
59. Wishart, D. S., Sykes, B. D., and Richards, F. M. (1992) The chemical shift index: A fast and simple method for the assignment of protein secondary structure through NMR spectroscopy Biochemistry 31, 1647-1651
60. Hutchinson, E. G. and Thornton, J. M. (1996) PROMOTIF: A program to identify and analyze structural motifs in proteins Protein Sci. 5, 212-220
61. Baldwin, J. M., Schertler, G. F., and Unger, V. M. (1997) An α-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors J. Mol. Biol. 272, 144-164
62. Shim, J. Y., Welsh, W. J., and Howlett, A. C. (2003) Homology model of the CB1 cannabinoid receptor: Sites critical for nonclassical cannabinoid agonist interaction Biopolymers 71, 169-189
63. Shi, L., Liapakis, G., Xu, R., Guarnieri, F., Ballesteros, J. A., and Javitch, J. A. (2002) β2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch J. Biol. Chem. 277, 40989-40996
64. Reggio, P. H. (2003) Pharmacophores for ligand recognition and activation/inactivation of the cannabinoid receptors Curr. Pharm. Des. 9, 1607-1633
65. 1 cannabinoid receptor Biochem. Pharmacol. 60, 1315-1323
66. Pertwee, R. G. (2005) Inverse agonism and neutral antagonism at cannabinoid CB1 receptors Life Sci. 76, 1307-1324
67. Sargent, D. F. and Schwyzer, R. (1986) Membrane lipid phase as catalyst for peptide-receptor interactions Proc. Natl. Acad. Sci. U.S.A. 83, 5774-5778
68. Sankararamakrishnan, R. (2006) Recognition of GPCRs by peptide ligands and membrane compartments theory: Structural studies of endogenous peptide hormones in membrane environment Biosci. Rep. 26, 131-158
69. Zdobinsky, T., Scherkenbeck, J., Zerbe, O., Antonicek, H., and Chen, H. (2009) Structures of micelle-bound selected insect neuropeptides and analogues: Implications for receptor selection ChemBioChem 10, 2644-2653
70. Scrima, M., Campiglia, P., Esposito, C., Gomez-Monterrey, I., Novellino, E., and D'Ursi, A. M. (2007) Obestatin conformational features: A strategy to unveil obestatin's biological role? Biochem. Biophys. Res. Commun. 363, 500-505
71. D'Ursi, A. M., Albrizio, S., Di Fenza, A., Crescenzi, O., Carotenuto, A., Picone, D., Novellino, E., and Rovero, P. (2002) Structural studies on Hgr3 orphan receptor ligand prolactin-releasing peptide J. Med. Chem. 45, 5483-5491
72. Dodd, G. T., Mancini, G., Lutz, B., and Luckman, S. M. (2010) The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice J. Neurosci. 30, 7369-7376